Stay updated on Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page
- Check3 days agoChange DetectedAdded “Prostate cancer” related topics, including MedlinePlus Genetics, as reference links on the page.SummaryDifference0.2%

- Check10 days agoChange DetectedRevision: v3.5.2 was added. Prostate cancer and the related topic MedlinePlus Genetics were removed, and Revision: v3.5.0 was removed.SummaryDifference0.2%

- Check17 days agoChange DetectedAdded related topics to the study record: Prostate cancer and MedlinePlus Genetics.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision updated to v3.5.0; the previous revision v3.4.3 has been removed.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed, indicating a minor page version update.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved Prostate cancer and the related topic MedlinePlus Genetics from the related topics section.SummaryDifference0.2%

Stay in the know with updates to Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.